Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Entheon Biomedical Corp ENTBF


Primary Symbol: C.ENBI

Healthcare Biotechnology
Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

Current News (CSE:ENBI)

Entheon Announces Change of Directors

Newsfile April 4, 2025

Entheon Issues Incentive Stock Options

Newsfile March 31, 2025

Entheon Announces Termination of Mentis AI Agreement

Newsfile March 14, 2025

Canadian Investment Regulatory Organization Trade Resumption - ENBI

Canada NewsWire January 24, 2025

Entheon Announces Agreement to Acquire Mentis AI

Newsfile January 24, 2025

Canadian Investment Regulatory Organization Trading Halt - ENBI

Canada NewsWire January 24, 2025

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

GlobeNewswire December 7, 2022

Entheon (CSE:ENBI) closes sale of DMT clinical assets

John Ballem  July 11, 2022

Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets

Newsfile July 11, 2022
View More News ››

Opinion & Analysis (CSE:ENBI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:ENBI)

RE:Another big up day.

Smoke and mirrors. $0.00 in revenue. Zero communication with shareholders over the last few years. Office phone lines disconnected...
Tslayer - January 25, 2025

Another big up day.

Rumours of ENBI death greatly exaggerated! Buying AI company and have raised piles of money. 
bigcomeback - January 24, 2025

RE:RE:Forgotten

Stock halted. Acquiring AI company..
bigcomeback - January 24, 2025

RE:Forgotten

I doubt anything is happening with phone lines disconnected  and website last updated in March 2022. Tough to run a business with...
Tslayer - January 21, 2025

Forgotten

Amazing how there has not been one post since the stock has rallied 500 percent after the split and done two financings. Maybe just maybe...
bigcomeback - January 14, 2025

reverse split

another one bites the dust. 
jerryfurberules - March 18, 2024
View more Bullboard ››

Walker Lane Resources Ltd.

Walker Lane Resources Ltd.

Walker Lane Resources Ltd. engages in the acquisition and exploration of mineral properties in Canada. The company explores ...
View More »